InsiderClue
Insiders · Profile

Vaishnaw Akshay

President of R&D at Scholar Rock · President at ALNYLAM PHARMACEUTICALS. Filing since 16 Jul 2012. CIK 0001458494

SRRK Scholar Rock Holding Corp President of R&D · 3 trades ALNY ALNYLAM PHARMACEUTICALS, INC. President · 36 trades
Company
Date
Role
Action
Shares
Amount
Of holding
SRRK Scholar Rock Holding Corp
16 Apr 2026
President of R&D
Sold at will
12,246
$607.09K
1.9%
SRRK Scholar Rock Holding Corp
13 Jan 2026
President of R&D
Sold at will
20,438
$872.70K
3.3%
SRRK Scholar Rock Holding Corp
29 May 2025
President of R&D
Sold on a plan
6,750
$200.61K
1.1%
ALNY ALNYLAM PHARMACEUTICALS, INC.
4 Aug 2023
President
Sold at will
4,057
$753.99K
15.1%
ALNY ALNYLAM PHARMACEUTICALS, INC.
27 Apr 2023
President
Sold at will
2,392
$465.46K
11.8%
ALNY ALNYLAM PHARMACEUTICALS, INC.
10 Feb 2023
President
Sold, plan not stated
38,044
$8.22M
71.8%
ALNY ALNYLAM PHARMACEUTICALS, INC.
23 Dec 2021
President, R&D
Sold, plan not stated
2,879
$549.70K
20.4%
ALNY ALNYLAM PHARMACEUTICALS, INC.
9 Aug 2021
President, R&D
Sold, plan not stated
10,834
$2.17M
49.1%
ALNY ALNYLAM PHARMACEUTICALS, INC.
18 Jun 2021
President, R&D
Sold, plan not stated
14,708
$2.57M
56.7%
ALNY ALNYLAM PHARMACEUTICALS, INC.
21 Apr 2021
President, R&D
Sold, plan not stated
2,732
$374.13K
16.2%
ALNY ALNYLAM PHARMACEUTICALS, INC.
19 Apr 2021
President, R&D
Sold, plan not stated
3,706
$510.19K
16.2%
ALNY ALNYLAM PHARMACEUTICALS, INC.
29 Sep 2020
President, R&D
Sold, plan not stated
971
$135.94K
6.4%
ALNY ALNYLAM PHARMACEUTICALS, INC.
22 Jun 2020
President, R&D
Sold, plan not stated
970
$146.54K
6.4%
ALNY ALNYLAM PHARMACEUTICALS, INC.
20 Apr 2020
President, R&D
Sold, plan not stated
21,971
$3.08M
60.9%
ALNY ALNYLAM PHARMACEUTICALS, INC.
7 Feb 2020
President, R&D
Sold, plan not stated
23,708
$2.96M
67.9%
ALNY ALNYLAM PHARMACEUTICALS, INC.
14 Mar 2018
President, R&D
Sold, plan not stated
88,554
$12.67M
88.8%
ALNY ALNYLAM PHARMACEUTICALS, INC.
30 Oct 2017
EVP, R&D
Sold, plan not stated
33,666
$4.09M
74.5%
ALNY ALNYLAM PHARMACEUTICALS, INC.
23 May 2017
EVP, R&D
Sold, plan not stated
11,000
$825.00K
51.7%
ALNY ALNYLAM PHARMACEUTICALS, INC.
15 May 2017
SVP, R&D
Sold, plan not stated
43,750
$2.84M
80.9%
ALNY ALNYLAM PHARMACEUTICALS, INC.
30 Nov 2016
EVP, R&D, CMO
Sold, plan not stated
29,165
$1.31M
83.5%
ALNY ALNYLAM PHARMACEUTICALS, INC.
16 Jun 2015
EVP, R&D, CMO
Sold, plan not stated
8,750
$1.13M
100%
ALNY ALNYLAM PHARMACEUTICALS, INC.
17 Mar 2015
EVP, R&D, CMO
Sold, plan not stated
8,750
$1.02M
100%
ALNY ALNYLAM PHARMACEUTICALS, INC.
16 Dec 2014
EVP, Chief Medical Officer
Sold, plan not stated
10,626
$994.59K
100%
ALNY ALNYLAM PHARMACEUTICALS, INC.
16 Sep 2014
EVP, Chief Medical Officer
Sold, plan not stated
10,625
$765.46K
100%
ALNY ALNYLAM PHARMACEUTICALS, INC.
17 Jun 2014
EVP, Chief Medical Officer
Sold, plan not stated
10,625
$741.80K
100%
ALNY ALNYLAM PHARMACEUTICALS, INC.
18 Mar 2014
EVP, Chief Medical Officer
Sold, plan not stated
32,769
$2.42M
100%
ALNY ALNYLAM PHARMACEUTICALS, INC.
24 Jan 2014
EVP, Chief Medical Officer
Sold, plan not stated
7,890
$676.59K
100%
ALNY ALNYLAM PHARMACEUTICALS, INC.
17 Dec 2013
EVP, Chief Medical Officer
Sold, plan not stated
18,480
$1.13M
59.5%
ALNY ALNYLAM PHARMACEUTICALS, INC.
16 Dec 2013
EVP, Chief Medical Officer
Sold, plan not stated
15,000
$905.30K
54.4%
ALNY ALNYLAM PHARMACEUTICALS, INC.
10 Sep 2013
EVP, Chief Medical Officer
Sold, plan not stated
6,250
$359.24K
33.2%
ALNY ALNYLAM PHARMACEUTICALS, INC.
11 Jun 2013
EVP, Chief Medical Officer
Sold, plan not stated
15,000
$466.14K
54.4%
ALNY ALNYLAM PHARMACEUTICALS, INC.
11 Mar 2013
EVP, Chief Medical Officer
Sold, plan not stated
6,250
$153.42K
33.2%
ALNY ALNYLAM PHARMACEUTICALS, INC.
12 Dec 2012
EVP, Chief Medical Officer
Sold, plan not stated
10,000
$190.00K
44.3%
ALNY ALNYLAM PHARMACEUTICALS, INC.
10 Dec 2012
EVP, Chief Medical Officer
Sold, plan not stated
4,777
$81.21K
27.5%
ALNY ALNYLAM PHARMACEUTICALS, INC.
4 Dec 2012
EVP, Chief Medical Officer
Sold, plan not stated
2,400
$40.90K
16.0%
ALNY ALNYLAM PHARMACEUTICALS, INC.
30 Nov 2012
EVP, Chief Medical Officer
Sold, plan not stated
2,823
$48.07K
18.3%
ALNY ALNYLAM PHARMACEUTICALS, INC.
12 Sep 2012
EVP, Chief Medical Officer
Sold, plan not stated
4,916
$93.40K
28.1%
ALNY ALNYLAM PHARMACEUTICALS, INC.
10 Sep 2012
EVP, Chief Medical Officer
Sold, plan not stated
1,334
$25.35K
9.6%
ALNY ALNYLAM PHARMACEUTICALS, INC.
16 Jul 2012
SVP, Chief Medical Officer
Sold, plan not stated
36,250
$688.75K
74.2%
39 decisions on file.